Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletion

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 6, 2011, Pages 2818-2823

  Jo, Dae Sun ^a,b   Montgomery, Christopher P ^a   Yin, Shaohui ^a   Boyle Vavra, Susan ^a   Daum, Robert S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

OXACILLIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG BLOOD LEVEL; GENE DELETION; INOCULATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; OPERON; PRIORITY JOURNAL; SKIN NECROSIS; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCAL SKIN INFECTION; SURVIVAL; TREATMENT OUTCOME; VRAR GENE; VRAS GENE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BACTERIAL PROTEINS; DNA-BINDING PROTEINS; GENE DELETION; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED C57BL; OPERON; OXACILLIN; PNEUMONIA, STAPHYLOCOCCAL; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 79956332479     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01704-10     Document Type: Article

References (32)

1. Arnaud, M., A. Chastanet, and M. Debarbouille. 2004. New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl. Environ. Microbiol. 70:6887-6891.
2. Augustin, J., and F. Gotz. 1990. Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS Microbiol. Lett. 54:203-207.
3. Axline, S. G., S. J. Yaffe, and H. J. Simon. 1967. Clinical pharmacology of antimicrobials in premature infants. II. Ampicillin, methicillin, oxacillin, neomycin, and colistin. Pediatrics 39:97-107.
4. Baxter Healthcare Corp. 3 November 2010, accession date. Oxacillin (oxacillin sodium) injection, solution. Baxter Healthcare Corp., Deerfield, IL. http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=4055.
5. Boyle-Vavra, S., S. Yin, M. Challapalli, and R. S. Daum. 2003. Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin. Antimicrob. Agents Chemother. 47:1028-1036.
6. Boyle-Vavra, S., S. Yin, and R. S. Daum. 2006. The VraS/VraR two-component regulatory system required for oxacillin resistance in community-acquired methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 262:163-171.
7. Chambers, H. F. 1997. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10:781-791.
8. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. CLSI M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Daum, R. S. 2007. Clinical practice: skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N. Engl. J. Med. 357:380-390.
10. David, M. Z., and R. S. Daum. 2010. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23:616-687.
11. Fridkin, S. K., et al. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436-1444.
12. Gardete, S., S. W. Wu, S. Gill, and A. Tomasz. 2006. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:3424-3434. (Pubitemid 44527519)
13. Infectious Diseases Society of America. 2010. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin. Infect. Dis. 50:1081-1083.
14. Ito, T., et al. 2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:1323-1336. (Pubitemid 32374098)
15. Jevons, M. P. 1961. "Celbenin"-resistant staphylococci. BMJ 1:124-125.
16. Katayama, Y., H. Z. Zhang, D. Hong, and H. F. Chambers. 2003. Jumping the barrier to beta-lactam resistance in Staphylococcus aureus. J. Bacteriol. 185:5465-5472.
17. Kind, A. C., T. E. Tupasi, H. C. Standiford, and W. M. M. Kirby. 1970. Mechanisms responsible for plasma levels of nafcillin lower than those of oxacillin. Arch. Intern. Med. 125:685-690.
18. Klevens, R. M., et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771.
19. Kreiswirth, B. N., et al. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712. (Pubitemid 13021519)
20. Kuroda, M., et al. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821. (Pubitemid 36918698)
21. Lee, C. Y., S. L. Buranen, and Z. H. Ye. 1991. Construction of single-copy integration vectors for Staphylococcus aureus. Gene 103:101-105.
22. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
23. McKinney, T. K., V. K. Sharma, W. A. Craig, and G. L. Archer. 2001. Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and beta-lactamase regulators. J. Bacteriol. 183:6862-6868.
24. Montgomery, C. P., et al. 2008. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J. Infect. Dis. 198:561-570.
25. Montgomery, C. P., S. Boyle-Vavra, and R. S. Daum. 2009. The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background. Infect. Immun. 77:2650-2656.
26. Montgomery, C. P., S. Boyle-Vavra, and R. S. Daum. 2010. Importance of the global regulators agr and saeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One 5:e15177.
27. Moran, G. J., et al. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
28. Pinho, M. G., H. de Lencastre, and A. Tomasz. 2001. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Proc. Natl. Acad. Sci. U. S. A. 98:10886-10891.
29. Simon, H. J., and E. J. Yin. 1970. Microbioassay of antimicrobial agents. Appl. Microbiol. 19:573-579.
30. Tiemersma, E. W., et al. 2004. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg. Infect. Dis. 10:1627-1634.
31. Utaida, S., et al. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719-2732.
32. Yin, S., R. S. Daum, and S. Boyle-Vavra. 2006. VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:336-343. (Pubitemid 43042941)